WHO-ESCEO Innovation Prize
The WHO-ESCEO Innovation Prize recognizes and promotes innovative technologies and research that contribute to the prevention, management, and treatment of osteoporosis, fragility fractures, and osteoarthritis. Selected applicants will have 7 minutes to present their work during the WHO-ESCEO Bone and Joint Innovative Session, taking place on 8 April 2027 in Vienna.
Three prestigious awards will be presented:
- WHO-ESCEO Innovation Prize for Osteoarthritis Research
- WHO-ESCEO Innovation Prize for Academic Research in Osteoporosis
- WHO-ESCEO Innovation Prize for Corporate Research in Osteoporosis
Together, these three prizes aim to highlight scalable and impactful solutions, spanning both academic and corporate innovation, that improve musculoskeletal health outcomes globally.
In addition to these awards, applications demonstrating a high level of scientific excellence will receive a WHO Collaborating Centre–ESCEO Certificate of Excellence, recognising outstanding innovation even if not selected for one of the Innovation Prizes.
Application process
-
Submission categories
- Osteoarthritis Research
- Academic Research in Osteoporosis
- Corporate Research in Osteoporosis
-
Eligibility
For the Bone Component, participation will be open and limited to corporate members of PRECCO as well as academic researchers.
For the Joint Component, this inaugural edition will be open exclusively to corporate partners.
- Innovations should be at least in the prototype or early implementation stage with demonstrated feasibility.
- Preference will be given to solutions that address equity, accessibility, and usability among older adults.
- For osteoarthritis, a preliminary selection of the applicants will be made by the ESCEO Scientific Advisory Board in collaboration with WHO Executives, two months prior to the Congress.
-
Submission process and timeline
Activity Timeline (2026-27) Details Call for Submissions Opens 2 November 2026 Submission of proposal — 5 pages (max) Deadline for Submissions 15 January 2027 All applications must be submitted by this time. Initial Review by ESCEO / WHO 15 January – 15 February 2027 Review submissions for eligibility. Public Pitching Session 8 April 2027 Applicants present innovations during WCO-IOF-ESCEO, before the Opening Ceremony. Award Ceremony 8 April 2027 Winners announced at the Opening Ceremony of the WCO-IOF-ESCEO. -
Judging process
Judging Panel
- Jotheeswaran Amuthavalli Thiyagarajan
Department of Sexual, Reproductive, Maternal, Newborn, Child and Adolescent Health and Ageing, WHO HQ - Sameer Pujari
Lead AI at WHO, Vice Chair AI 4 health WHO ITU expert group, Department of Digital Health & Innovation, WHO, HQ - Rene Rizzoli
Chair of WHO BOHEG (Bone Health Expert Working Group), Geneva, Switzerland
Judges' Responsibilities
- Review the submissions
- Shortlist the finalists
- Attend the public pitching session during WCO-IOF-ESCEO 2027
- Evaluate each innovation using a standardized scorecard provided in advance
- Submit rankings by April 2027
- Jotheeswaran Amuthavalli Thiyagarajan
-
Evaluation Criteria
- Innovation and creativity – Novelty and originality of the concept.
- Impact and relevance – Potential to improve prevention or rehabilitation.
- Feasibility and scalability – Viability of implementation and potential for broader adoption.
- Equity and accessibility – Contribution to reducing disparities, including for low-resource settings.
- User-centric design – Usability, engagement, and responsiveness to older adults’ needs.
- Evidence of effectiveness – Data or pilot results demonstrating measurable impacts.
-
Contact information
For any questions regarding the submission process or eligibility, please contact Professor René Rizzoli.
-
How to submit
Please send your application to Mr. Martin Scheffer at scheffer@humacom.com.
Upon submission, applicants will receive an acknowledgement of receipt by email. If no acknowledgement is received within 48 hours, applicants are kindly requested to contact the Congress Secretariat to ensure that their application has been successfully received.